Clinical trials
Phase 1 Hypertension, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 9 |
| Recruiting | 7 |
| Unknown status | 5 |
| Withdrawn | 3 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| Bayer | 4 |
| GlaxoSmithKline | 3 |
| Bellerophon | 2 |
| Gladwin, Mark, MD | 2 |
| Merck Sharp & Dohme LLC | 2 |
| United Therapeutics | 2 |
| 35Pharma Inc | 1 |
| Aadi Bioscience, Inc. | 1 |
| Actelion | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 62 |
| Pulmonary Arterial Hypertension | 10 |
| Pulmonary Disease, Chronic Obstructive | 6 |
| Anemia, Sickle Cell | 5 |
| Bronchopulmonary Dysplasia | 3 |
| Familial Primary Pulmonary Hypertension | 3 |
| Heart Failure | 3 |
| Lung Diseases | 3 |
| Acute Chest Syndrome | 2 |
| Asthma | 2 |
Trials
Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.